476 related articles for article (PubMed ID: 24490763)
1. Drug-in-cyclodextrin-in-liposomes: a promising delivery system for hydrophobic drugs.
Chen J; Lu WL; Gu W; Lu SS; Chen ZP; Cai BC; Yang XX
Expert Opin Drug Deliv; 2014 Apr; 11(4):565-77. PubMed ID: 24490763
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 9-nitrocamptothecin-in-cyclodextrin-in-liposomes modified with transferrin for the treating of tumor.
Chen J; Lu S; Gu W; Peng P; Dong J; Xu F; Yang X; Xiong Z; Yang X
Int J Pharm; 2015 Jul; 490(1-2):219-28. PubMed ID: 26004006
[TBL] [Abstract][Full Text] [Related]
3. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation.
Mennini N; Cirri M; Maestrelli F; Mura P
Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance.
Hammoud Z; Khreich N; Auezova L; Fourmentin S; Elaissari A; Greige-Gerges H
Int J Pharm; 2019 Jun; 564():59-76. PubMed ID: 30959238
[TBL] [Abstract][Full Text] [Related]
5. Drug-in-hydroxypropyl-β-cyclodextrin-in-lipoid S100/cholesterol liposomes: Effect of the characteristics of essential oil components on their encapsulation and release.
Hammoud Z; Gharib R; Fourmentin S; Elaissari A; Greige-Gerges H
Int J Pharm; 2020 Apr; 579():119151. PubMed ID: 32070761
[TBL] [Abstract][Full Text] [Related]
6. First evaluation of drug-in-cyclodextrin-in-liposomes as an encapsulating system for nerolidol.
Azzi J; Auezova L; Danjou PE; Fourmentin S; Greige-Gerges H
Food Chem; 2018 Jul; 255():399-404. PubMed ID: 29571492
[TBL] [Abstract][Full Text] [Related]
7. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
8. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
[TBL] [Abstract][Full Text] [Related]
9. Liposomes incorporating cyclodextrin-drug inclusion complexes: Current state of knowledge.
Gharib R; Greige-Gerges H; Fourmentin S; Charcosset C; Auezova L
Carbohydr Polym; 2015 Sep; 129():175-86. PubMed ID: 26050903
[TBL] [Abstract][Full Text] [Related]
10. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
11. Double loading of cyclosporine A in liposomes using cyclodextrin complexes.
Malaekeh-Nikouei B; Davies N
PDA J Pharm Sci Technol; 2009; 63(2):139-48. PubMed ID: 19634352
[TBL] [Abstract][Full Text] [Related]
12. Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.
McCormack B; Gregoriadis G
J Drug Target; 1994; 2(5):449-54. PubMed ID: 7704490
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin complexes: Perspective from drug delivery and formulation.
Jacob S; Nair AB
Drug Dev Res; 2018 Aug; 79(5):201-217. PubMed ID: 30188584
[TBL] [Abstract][Full Text] [Related]
14. Delivery of fluorescent-labeled cyclodextrin by liposomes: role of transferrin modification and phosphatidylcholine composition.
Chen J; Yao J; Ma Z; Peng P; Lu S; Hu Y; Xu F; Yang Y; Yang X
J Liposome Res; 2017 Mar; 27(1):21-31. PubMed ID: 26911560
[TBL] [Abstract][Full Text] [Related]
15. Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: A review.
Mura P
Int J Pharm; 2020 Apr; 579():119181. PubMed ID: 32112928
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of α-Pinene in Delivery Systems Based on Liposomes and Cyclodextrins.
Hammoud Z; Kayouka M; Trifan A; Sieniawska E; Jemâa JMB; Elaissari A; Greige-Gerges H
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833931
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
18. Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition.
Hatzi P; Mourtas S; Klepetsanis PG; Antimisiaris SG
Int J Pharm; 2007 Mar; 333(1-2):167-76. PubMed ID: 17101248
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
20. Preparation of drug-in-cyclodextrin-in-liposomes at a large scale using a membrane contactor: Application to trans-anethole.
Gharib R; Greige-Gerges H; Jraij A; Auezova L; Charcosset C
Carbohydr Polym; 2016 Dec; 154():276-86. PubMed ID: 27577919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
